Free Newsletter
Bone marrow in test tube offers new tool to researchers
A lab at the University of Michigan has created artificial human bone marrow in a test tube, and the end product can be used to test new drugs more efficiently, study the human immune system and potentially create an unlimited supply of blood.
Nicholas Kotov, a professor in the U-M departments of Chemical Engineering; Materials Science and Engineering; and Biomedical Engineering, and Joan Nichols, professor from the University of Texas Medical Branch, developed a 3-D scaffold with a set of specially designed pores needed to stimulate cellular activity. And by having it available in a test tube, it will be readily available to researchers who want to test a new drug's effect on bone marrow.
"The geometrical perfection of the polymer molded by spheres is very essential for reproducibility of the drug tests and evaluation of potential drug candidates," Kotov said. "The scaffold for this work had to be designed from scratch closely mimicking real bone marrow because there are no suitable commercially products. Certain stem cells that are essential for immunity and blood production are able to grow, divide and differentiate efficiently in these scaffolds due to the close similarity of the pores in the scaffold and the pores in actual bone marrow."
- here's the release
- read the report in PhysOrg
Related Articles:
Scientists grow blood vessels from stem cells
ESCs provide a key to new blood supply
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: